Английская Википедия:Andrew Witty

Материал из Онлайн справочника
Версия от 14:17, 31 января 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|British business executive (born 1964)}} {{Use dmy dates|date=April 2017}} {{Infobox person | name = Sir Andrew Witty | image = AndrewWitty in 2023.jpg | alt = Andrew Witty wearing a suit | caption = Witty in 2023 | birth_date = {{birth date and age|1964|08|22|df=yes}} | occupation = CEO, UnitedH...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Use dmy dates Шаблон:Infobox person Sir Andrew Philip Witty (born 22 August 1964)[1] is a British business executive, who is the current chief executive officer (CEO) of UnitedHealth Group. He was also the CEO of GlaxoSmithKline between 2008 and 2017. He formerly held the role of chancellor of the University of Nottingham.[2]

Early life

Witty attended Malbank School (originally the "Nantwich and Acton Grammar School") in Nantwich, and then gained a bachelor's degree in economics from the University of Nottingham.[1][3]

Career

Witty joined Glaxo UK in 1985 as a management trainee.[4] He held various positions in the UK, including director of pharmacy & distribution in Glaxo Pharmaceuticals UK.[5]

He served as a vice president and general manager of marketing of Glaxo Wellcome Inc., a subsidiary of GlaxoSmithKline with responsibility for strategy development, marketing execution and new product positioning. He served as an economic adviser to the governor of Guangzhou, China, from 2000 to 2002.[6]

He was appointed president, Pharmaceuticals Europe of GlaxoSmithKline plc in January 2003[6] and succeeded Jean-Pierre Garnier as CEO following his retirement in May 2008. He was paid an annual salary of Шаблон:GBP and received bonuses and other compensation amounting to Шаблон:GBP for this role.[7][8]

In February 2009 he pledged to make a major change in the way GSK pharmaceuticals are priced, in an attempt to make vital drugs more affordable in countries with the lowest incomes. At the same time he announced that GSK would place certain patents in a pool so that they were freely available for others in the search for new drugs.[9]

From 2010 until 2015, Witty served on the business advisory board of Prime Minister of the United Kingdom, David Cameron.[10]

In October 2012 it was announced that he had been appointed the chancellor of the University of Nottingham with effect from 1 January 2013, having maintained strong ties with the university since graduation.[11] Witty announced his retirement from the role of chancellor in November 2017.[12]

In July 2013, the People's Republic of China announced that they were investigating allegations of fraud perpetrated by GSK going back to 2007 and involving thousands of millions of renminbi.[13] Witty stated "It appears that certain senior executives in the China business have acted outside our processes and controls to both defraud the company and the Chinese health care system. To see these allegations about people working for GSK is shameful. For me personally they are deeply disappointing."[14]

From 2013 to 2015, Witty served on the UNAIDS–Lancet Commission for Defeating AIDS and Advancing Global Health, co-chaired by Joyce Banda, Nkosazana Dlamini Zuma and Peter Piot.[15][16] From 2015 until 2016, he was a member of the UN High-Level Panel on Access to Medicines, led by Ruth Dreifuss and Festus Mogae.[17]

In November 2015, Witty's leadership of GSK was criticised by Neil Woodford, who said that "he’s not doing a very good job". Woodford called for GSK to be split into four companies.[18] In March 2016, Witty announced that he was to step down as chief executive.[19]

From 2017 until 2018, Witty led the National Health Service’s Accelerated Access Collaborative.[20][21]

In July 2018, Witty became CEO of Optum, a division of UnitedHealth Group.[22] In November 2019, he was named president of UnitedHealth, in addition to his role as CEO of Optum.[23]

In April 2020, Witty took a one-year leave of absence from Optum to assist the World Health Organization in developing a vaccine for COVID-19.[24] In May 2020, he was appointed to the expert advisory group for the UK Government's Vaccine Task Force, chaired by Patrick Vallance.[25]

Witty became CEO of UnitedHealth Group in February 2021.[26]

In April 2021, he was also appointed to the Pandemic Preparedness Partnership (PPP), an expert group chaired by Vallance to advise the G7 presidency held by the government of Prime Minister of the United Kingdom, Boris Johnson.[27]

Corporate Membership

Corporate boards

  • G1 Therapeutics, non-executive director (since 2017)[28]
  • Synthego, member of the advisory board (since 2017)[29]
  • Hatteras Venture Partners, advisor[30]

Non-profit organizations

Recognition

Witty was knighted in the 2012 New Year Honours for services to the economy and the UK pharmaceutical industry.[33] He was also conferred the Honorary Citizen of Singapore in 2018.[34]

References

Шаблон:Reflist

External links

Шаблон:S-start Шаблон:S-bus Шаблон:S-bef Шаблон:S-ttl Шаблон:S-aft Шаблон:S-aca Шаблон:S-bef Шаблон:S-ttl Шаблон:S-aft Шаблон:S-end Шаблон:University of Nottingham

Шаблон:GlaxoSmithKline

Партнерские ресурсы
Криптовалюты
Магазины
Хостинг
Разное

  1. ↑ 1,0 1,1 Шаблон:Cite news
  2. ↑ Шаблон:Cite web
  3. ↑ Шаблон:Cite news
  4. ↑ Шаблон:Cite webШаблон:Cbignore
  5. ↑ Шаблон:Cite web
  6. ↑ 6,0 6,1 6,2 Шаблон:Cite web
  7. ↑ Шаблон:Cite news
  8. ↑ Шаблон:Cite web
  9. ↑ Шаблон:Cite news
  10. ↑ Elizabeth Rigby and Sarah Gordon (27 July 2015), David Cameron replaces his entire business advisory board Financial Times.
  11. ↑ University of Nottingham appoints new Chancellor – The University of Nottingham
  12. ↑ Шаблон:Cite news
  13. ↑ Шаблон:Cite news
  14. ↑ Шаблон:Cite newsШаблон:Cbignore
  15. ↑ New UNAIDS and Lancet Commission to explore HIV and global health in the Post-2015 debate UNAIDS, press release of 26 May 2013.
  16. ↑ UNAIDS and Lancet Commission address strategic challenges for the future of AIDS and global health UNAIDS, press release of 1 July 2013.
  17. ↑ United Nations Secretary-General’s High-Level Panel on Access to Medicines Calls For New Deal to Close the Health Innovation and Access Gap UN High-Level Panel on Access to Medicines, press release of 14 September 2016.
  18. ↑ Шаблон:Cite web
  19. ↑ Шаблон:Cite web
  20. ↑ Accelerated access scheme means patients will get new treatments faster Department of Health and Social Care, press release of 3 November 2017.
  21. ↑ New chair appointed to improve patient access to innovation in the NHS Department of Health and Social Care, press release of 19 June 2018.
  22. ↑ Шаблон:Cite web
  23. ↑ Шаблон:Cite web
  24. ↑ Шаблон:Cite news
  25. ↑ Funding and manufacturing boost for UK vaccine programme Government of the United Kingdom, press release of 17 May 2020.
  26. ↑ Шаблон:Cite news
  27. ↑ New global partnership launched to fight future pandemics Government of the United Kingdom, press release of April 20, 2021.
  28. ↑ G1 Therapeutics Appoints Sir Andrew Witty to Board of Directors G1 Therapeutics, press release of 13 July 2017.
  29. ↑ Sir Andrew Witty, Former CEO of GSK, Joins Synthego Advisory Board Synthego, press release of 20 September 2017.
  30. ↑ Andrew Witty Hatteras Venture Partners.
  31. ↑ Michael Mills (18 June 2020), WHO COVID-19 vaccine co-lead appointed to head Business School Advisory Board Imperial College Business School.
  32. ↑ Global Advisory Board Duke Institute for Health Innovation (DIHI).
  33. ↑ Шаблон:London Gazette
  34. ↑ Шаблон:Cite web
Источник — http://wikihandbk.com/ruwiki/index.php?title=Английская_Википедия:Andrew_Witty&oldid=13148880